Opus Genetics (IRD) Total Liabilities (2010 - 2026)

Opus Genetics (IRD) has 17 years of Total Liabilities data on file, last reported at $87.9 million in Q1 2026.

• On a quarterly basis, Total Liabilities rose 262.41% year-over-year to $87.9 million in Q1 2026; TTM through Mar 2026 was $87.9 million, a 262.41% increase from a year earlier, with the FY2025 full-year figure at $34.9 million, up 208.94% from the prior year.
• Total Liabilities for Q1 2026 stood at $87.9 million, up from $34.9 million in the prior quarter.
• Over the last five years, Total Liabilities for IRD reached as high as $87.9 million in Q1 2026 and fell as low as $2.7 million in Q3 2022.
• Historically, Total Liabilities has averaged $15.0 million across 5 years, with a median of $5.8 million in 2023.
• Across the five-year window, Total Liabilities declined 28.59% in 2022 and surged 404.81% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $2.8 million in 2022, then surged by 46.82% to $4.0 million in 2023, then surged by 179.44% to $11.3 million in 2024, then surged by 208.94% to $34.9 million in 2025, then surged by 151.86% to $87.9 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $87.9 million in Q1 2026, $34.9 million in Q4 2025, and $30.2 million in Q3 2025.